| NCT06917508 | A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants | COMPLETED | PHASE1 | 2025-03-13 | 2025-06-13 | 2025-06-06 |
| NCT06847464 | A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. | COMPLETED | PHASE1 | 2025-01-27 | 2025-06-01 | 2025-05-24 |
| NCT06601192 | A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults | COMPLETED | PHASE1 | 2024-07-15 | 2025-02-25 | 2025-02-02 |
| NCT06170242 | A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model | COMPLETED | PHASE2 | 2023-11-20 | 2024-07-12 | 2024-06-17 |
| NCT05568706 | A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. | COMPLETED | PHASE2 | 2022-11-29 | 2025-06-23 | 2025-06-23 |
| NCT05616728 | A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 | COMPLETED | PHASE2 | 2022-11-10 | 2023-06-29 | 2023-02-08 |
| NCT05594615 | Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects | COMPLETED | PHASE1 | 2022-10-06 | 2022-11-18 | 2022-11-04 |
| NCT05594602 | Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects. | COMPLETED | PHASE1 | 2022-10-06 | 2022-12-30 | 2022-12-14 |
| NCT05587478 | A Study of EDP-323 in Healthy Subjects | COMPLETED | PHASE1 | 2022-09-29 | 2023-03-29 | 2023-03-29 |
| NCT04816721 | A Study to Evaluate EDP 938 Regimens in Children With RSV | COMPLETED | PHASE2 | 2022-04-26 | 2024-08-19 | 2024-08-19 |
| NCT05246878 | A Study of EDP-235 in Healthy Subjects | COMPLETED | PHASE1 | 2022-01-28 | 2022-07-20 | 2022-07-20 |
| NCT04971512 | A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION. | TERMINATED | PHASE1 | 2021-08-02 | 2021-12-20 | 2021-12-20 |
| NCT04633187 | Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract | TERMINATED | PHASE2 | 2021-07-07 | 2023-05-31 | 2023-05-31 |
| NCT04927793 | Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects | COMPLETED | PHASE1 | 2021-05-28 | 2021-07-04 | 2021-07-04 |
| NCT04871724 | Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects | COMPLETED | PHASE1 | 2021-03-12 | 2021-04-16 | 2021-03-30 |
| NCT04783753 | Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects | COMPLETED | PHASE1 | 2020-11-05 | 2021-07-09 | 2021-06-28 |
| NCT04470388 | A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment | COMPLETED | PHASE1 | 2020-09-09 | 2021-08-30 | 2021-08-30 |
| NCT04559126 | A Study of EDP-297 in Healthy Subjects | COMPLETED | PHASE1 | 2020-09-08 | 2021-06-21 | 2021-06-21 |
| NCT04498741 | Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects | COMPLETED | PHASE1 | 2020-07-08 | 2021-06-01 | 2021-05-27 |
| NCT04378010 | A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH | TERMINATED | PHASE2 | 2020-01-27 | 2021-11-30 | 2021-10-04 |
| NCT04196101 | A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects | COMPLETED | PHASE2 | 2020-01-22 | 2022-01-04 | 2022-01-04 |
| NCT04008004 | A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) | COMPLETED | PHASE1 | 2019-06-26 | 2021-07-14 | 2021-07-14 |
| NCT03755778 | Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects | COMPLETED | PHASE1 | 2018-11-29 | 2019-01-27 | 2019-01-21 |
| NCT03783897 | A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects | COMPLETED | PHASE1 | 2018-11-27 | 2019-06-18 | 2019-06-04 |
| NCT03750383 | Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects | COMPLETED | PHASE1 | 2018-11-02 | 2018-12-13 | 2018-11-17 |
| NCT03691623 | A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model | COMPLETED | PHASE2 | 2018-10-15 | 2019-10-18 | 2019-09-30 |
| NCT03748628 | Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects | COMPLETED | PHASE1 | 2018-10-05 | 2018-10-13 | 2018-10-13 |
| NCT03610945 | Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers | COMPLETED | PHASE1 | 2018-07-19 | 2018-08-21 | 2018-08-15 |
| NCT03421431 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis | COMPLETED | PHASE2 | 2018-04-25 | 2019-07-10 | 2019-06-14 |
| NCT03394924 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis | COMPLETED | PHASE2 | 2017-12-27 | 2020-01-16 | 2019-12-19 |
| NCT03384823 | A Study of EDP-938 in Healthy Subjects | COMPLETED | PHASE1 | 2017-12-07 | 2018-07-03 | 2018-07-03 |
| NCT03213145 | Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers | COMPLETED | PHASE1 | 2017-07-11 | 2017-09-07 | 2017-08-10 |
| NCT03207425 | A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers | COMPLETED | PHASE1 | 2017-06-14 | 2017-09-19 | 2017-09-16 |
| NCT03187496 | Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. | COMPLETED | PHASE1 | 2017-05-11 | 2017-06-14 | 2017-06-01 |
| NCT02918929 | A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD | COMPLETED | PHASE1 | 2016-09 | 2017-06 | 2017-06 |
| NCT02652377 | EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients | COMPLETED | PHASE1 | 2016-01-10 | 2016-12-27 | 2016-12-27 |
| NCT02255968 | Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788 | TERMINATED | PHASE1 | 2014-08 | 2014-10 | 2014-10 |
| NCT02173574 | Two-way Interaction Between Alisporivir and EDP239 | COMPLETED | PHASE1 | 2014-08 | 2014-11 | 2014-11 |
| NCT01999725 | Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788 | COMPLETED | PHASE1 | 2014-01 | 2014-09 | 2014-09 |
| NCT01856426 | Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects | COMPLETED | PHASE1 | 2013-06 | 2015-10 | 2014-11 |
| NCT00990145 | Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers | COMPLETED | PHASE1 | 2008-11 | 2009-09 | 2009-03 |
| NCT00270517 | Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia | UNKNOWN | PHASE2 | 2005-12 | 2007-07 | |
| NCT00989872 | Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers | COMPLETED | PHASE1 | | | |